Efficacy of Continuous Sciatic Nerve Block in Diabetic Foot Patients

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 10, 2019

Primary Completion Date

December 1, 2021

Study Completion Date

January 28, 2023

Conditions
Diabetic FootRegional AnesthesiaCatheter BlockageWound Heal
Interventions
PROCEDURE

Group C (Continuous sciatic nerve block)

Patients randomized to this group will receive a sciatic nerve block with the catheter tip insertion at the popliteal location 1-3 cm cephalad to the sciatic bifurcation. After Catheter placement outcome measures will be assessed.

PROCEDURE

Group S (sciatic nerve block)

Patients randomized to this group will receive a sciatic nerve block at the popliteal location 1-3 cm cephalad to the sciatic bifurcation. After single injection sciatic nerve block, outcome measures will be assessed.

Trial Locations (1)

06100

Gulhane Training and Research Hospital, Ankara

All Listed Sponsors
lead

Gulhane School of Medicine

OTHER

NCT04212325 - Efficacy of Continuous Sciatic Nerve Block in Diabetic Foot Patients | Biotech Hunter | Biotech Hunter